109 related articles for article (PubMed ID: 8865125)
41. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
[TBL] [Abstract][Full Text] [Related]
42. Serum-soluble E-cadherin fragments in lung cancer.
Cioffi M; Gazzerro P; Di Finizio B; Vietri MT; Di Macchia C; Puca GA; Molinari AM
Tumori; 1999; 85(1):32-4. PubMed ID: 10228494
[TBL] [Abstract][Full Text] [Related]
43. Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS.
Pujol JL; Grenier J; Parrat E; Lehmann M; Lafontaine T; Quantin X; Michel FB
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):725-33. PubMed ID: 8810612
[TBL] [Abstract][Full Text] [Related]
44. Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma.
Boyano MD; García-Vázquez MD; Gardeazabal J; García de Galdeano A; Smith-Zubiaga I; Cañavate ML; Raton JA; Bilbao I; Díaz-Pérez JL
Oncology; 1997; 54(5):400-6. PubMed ID: 9260602
[TBL] [Abstract][Full Text] [Related]
45. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
[TBL] [Abstract][Full Text] [Related]
46. Interleukin 2 soluble receptor (s-IL 2R) and lung cancer.
Pecchio F; Rapellino M; Aimo G; Baldi S; Cunazza M; Libertucci D; Cavallo A; Oliaro A; Pagni R
J Nucl Med Allied Sci; 1990; 34(4 Suppl):163-7. PubMed ID: 2092112
[No Abstract] [Full Text] [Related]
47. Soluble immunological parameters and early prognosis of renal cell cancer patients.
Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL
J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
[TBL] [Abstract][Full Text] [Related]
48. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
49. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
[TBL] [Abstract][Full Text] [Related]
50. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
51. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
52. Soluble interleukin-2 receptor levels in patients with dermatitis herpetiformis.
Ward MM; Pisetsky DS; Hall RP
J Invest Dermatol; 1991 Sep; 97(3):568-72. PubMed ID: 1875055
[TBL] [Abstract][Full Text] [Related]
53. A progressive postoperative increase in the serum level of soluble receptors for interleukin-2 is an indicator of a poor prognosis in patients with gastric cancer.
Maeta M; Saito H; Katano K; Kondo A; Tsujitani S; Makino M; Ikeguchi M; Kaibara N
Int J Mol Med; 1998 Jan; 1(1):113-6. PubMed ID: 9852207
[TBL] [Abstract][Full Text] [Related]
54. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
55. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M
Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-1 alpha, interleukin-2, and soluble interleukin-2 receptors in polymyositis.
Wolf RE; Baethge BA
Arthritis Rheum; 1990 Jul; 33(7):1007-14. PubMed ID: 2369417
[TBL] [Abstract][Full Text] [Related]
57. Mechanism of increased serum soluble interleukin-2 receptor levels in patients on continuous ambulatory peritoneal dialysis.
Takemasa A; Yorioka N; Oda H; Amimoto D; Ito T; Yamakido M
Scand J Urol Nephrol; 2001 Apr; 35(2):141-6. PubMed ID: 11411658
[TBL] [Abstract][Full Text] [Related]
58. Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis.
Pforte A; Brunner A; Gais P; Burger G; Breyer G; Ströbel M; Häussinger K; Ziegler-Heitbrock HW
Am Rev Respir Dis; 1993 Mar; 147(3):717-22. PubMed ID: 7680189
[TBL] [Abstract][Full Text] [Related]
59. [Changes of serum interleukin 2 and soluble interleukin 2 receptor and their clinical significance in multiple myeloma].
Wang Z; Li D; Yang J
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):439-41. PubMed ID: 9387297
[TBL] [Abstract][Full Text] [Related]
60. Increase of serum interleukin 2 receptor level in thermally injured patients.
Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Falk RE; Peters WJ
Clin Immunol Immunopathol; 1989 May; 51(2):205-15. PubMed ID: 2784753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
